Co-Diagnostics Q1 2024 GAAP EPS $(0.31) Misses $(0.21) Estimate, Sales $467.854K Miss $3.050M Estimate
Co-Diagnostics Q1 2024 GAAP EPS $(0.31) Misses $(0.21) Estimate, Sales $467.854K Miss $3.050M Estimate
聯合診斷2024年第一季度GAAP每股收益（0.31）未達到預期（0.21），銷售額爲46.7854萬美元，未達到30.5億美元的預期
Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.21) by 47.62 percent. This is a 55 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $467.854 thousand which missed the analyst consensus estimate of $3.050 million by 84.66 percent. This is a 22.28 percent decrease over sales of $601.957 thousand the same period last year.
聯合診斷（納斯達克股票代碼：CODX）公佈的季度虧損爲每股0.31美元，比分析師普遍預期的0.21美元（0.21美元）低47.62個百分點。這比去年同期每股虧損0.20美元（0.20）下降了55％。該公司公佈的季度銷售額爲467,854美元，比分析師普遍預期的30.5億美元低84.66％。這比去年同期的601,957美元的銷售額下降了22.28％。